Heart and Lung Institute, University hospital of Lille, F-59000 Lille, France. Univ. Lille, F-59000, France. Institut Pasteur of Lille, Inserm U1011, F-59000 Lille, France. FACT (French Alliance for Cardiovascular Trials), F-75000 Paris, France.
Department of Cardiology, Hôpital Européen Georges Pompidou, AP-HP, University of Paris, and FACT (French Alliance for Cardiovascular Trials), Paris, France.
Diabetes Metab. 2022 Jan;48(1):101265. doi: 10.1016/j.diabet.2021.101265. Epub 2021 Jul 2.
We attempted to describe the risk of heart failure (HF) occurrence according to diabetes mellitus (DM) status in patients with coronary artery disease (CAD) over time, from acute myocardial infarction (MI) to the chronic stable phase.
For the acute and subacute MI phases, we analysed the FAST-MI cohort restricted to patients without history of HF (n = 12,473). The analysis on 1-year outcomes after MI was further restricted to patients who were discharged alive and without history of HF and/or HF symptoms during the index hospitalisation for MI (n = 9181). To analyse the chronic phase, we analysed the CORONOR cohort restricted to patients without history of HF (n = 3871). The primary endpoint was HF occurrence according to DM status. We also analysed the composite of all-cause death or HF.
Killip-Kimball class ≥II during the index MI hospitalisation was more frequent in DM patients compared to non-DM patients (29% vs. 15.3%, adjusted OR = 1.60). At one year after MI, hospitalisation for HF was more frequent in DM patients (3.3% vs. 1.2%, adjusted HR = 1.73). At the chronic phase (5-year outcomes), hospitalisation for HF was more frequent in DM patients (8.5% vs. 4.3%, adjusted HR = 1.70). Results focusing on the composite endpoint (all-cause death or HF) were consistent.
DM was associated with a very constant near 2-fold increase in the risk of HF whatever the presentation of CAD. Avoiding the risk of HF occurrence in CAD patients with DM is critical in daily practice and should be a constant life-long endeavour.
我们试图描述随着时间的推移,在患有冠状动脉疾病(CAD)的患者中,根据糖尿病(DM)状态,从急性心肌梗死(MI)到慢性稳定期发生心力衰竭(HF)的风险。
对于急性和亚急性 MI 阶段,我们分析了 FAST-MI 队列,该队列仅限于无 HF 病史的患者(n=12473)。MI 后 1 年结果的分析进一步限制在出院时存活且在 MI 住院期间无 HF 和/或 HF 症状史的患者(n=9181)。为了分析慢性期,我们分析了 CORONOR 队列,该队列仅限于无 HF 病史的患者(n=3871)。主要终点是根据 DM 状态发生 HF。我们还分析了全因死亡或 HF 的复合终点。
与非 DM 患者相比,DM 患者在 MI 住院期间的 Killip-Kimball 分级≥II 更为常见(29% vs. 15.3%,调整后的 OR=1.60)。在 MI 后 1 年,HF 住院更为常见(3.3% vs. 1.2%,调整后的 HR=1.73)。在慢性期(5 年结果),HF 住院更为常见(8.5% vs. 4.3%,调整后的 HR=1.70)。关注复合终点(全因死亡或 HF)的结果一致。
无论 CAD 的表现如何,DM 与 HF 风险增加近 2 倍密切相关。在 CAD 合并 DM 的患者中,避免 HF 发生的风险在日常实践中至关重要,应作为一项持续终生的努力。